"Enterovirus D68: an underestimated pathogen" - Slideset by professor Niesters (Chair of WAidid Working group on Virology) presented at the 2015 Annual Meeting of the Society for General Microbiology, held in Birmingham at the end of March 2015.
Find more on www.waidid.org
Erysipelothrix rhusiopathiae infection in pigs, pork and raw pork handlers in...ILRI
Presentation by Angella Musewa, Kristina Roesel, Damalie Nakanjako, Delia Grace, Ronald Ssenyonga, Joan Nangendo, Ismael Kawooya, Joseph Erume at the first joint conference of the Association of Institutions for Tropical Veterinary Medicine and the Society of Tropical Veterinary Medicine, Berlin, Germany, 4–8 September 2016.
This document discusses brucellosis, a zoonotic disease caused by bacteria of the genus Brucella. It primarily affects livestock such as cattle, goats, and pigs. The disease can be transmitted to humans through consumption of unpasteurized dairy products or contact with infected animals/tissues. Clinical features in humans include undulant fever and nonspecific symptoms affecting multiple organ systems. Diagnosis involves serological tests or culture of blood/tissues. Treatment consists of a combination of doxycycline and streptomycin or rifampin over several weeks. Prevention focuses on vaccination of livestock and avoiding raw dairy products.
Rhabdoviridae is a family of viruses that includes over 150 members, with rabies virus being the most important human pathogen. Rabies virus has a bullet-shaped structure with a linear, negative-sense single stranded RNA genome encapsulated by a nucleoprotein and surrounded by a lipid envelope containing glycoprotein spikes. Rabies virus is typically transmitted through the bite or scratch of an infected animal and causes fatal neurological disease in humans. While treatment after symptoms is ineffective, vaccination can prevent disease if administered promptly after exposure.
Adenovirus belongs to the family Adenoviridae
This is a double stranded DNA virus
Does not possess an envelope
Adenovirus is icosahedral in shape
Thus not easily destroyed
It’s name is given as this virus is first isolated from the add noise
But this virus can affect several systems and cause several illnesses
Adenovirus affects respiratory system, gastrointestinal system, genitourinary system and the eye
So this virus has many serotypes
This document provides information on various paramyxoviruses, including parainfluenza virus, mumps virus, measles virus, and respiratory syncytial virus (RSV). It describes their morphology, genome, taxonomy, pathogenesis, transmission, symptoms, complications, diagnosis, and treatment. The paramyxoviruses are enveloped viruses that contain single-stranded, negative-sense RNA genomes. They cause a variety of respiratory illnesses in humans and animals. Laboratory diagnosis involves antigen detection, virus isolation, serology, and molecular techniques like RT-PCR. Vaccines are available to prevent infections from some paramyxoviruses.
Adenoviruses are non-enveloped double stranded DNA viruses that are isolated from adenoid tissue. They cause respiratory, eye, urinary tract and intestinal infections in children and military recruits. There are over 50 serotypes classified into groups A through F. Symptoms vary depending on the infected site and serotype but include respiratory diseases, sore throat, follicular conjunctivitis and epidemic keratoconjunctivitis. Diagnosis involves tissue culture, complement fixation tests, PCR and electron microscopy. While there is no vaccine for general use, some vaccines exist to control outbreaks in closed communities.
Monkeypox is caused by an enveloped double-stranded DNA virus in the orthopoxvirus genus of the Poxviridae family. It can spread through direct contact with infectious rash, scabs, or body fluids, respiratory secretions during prolonged face-to-face contact, or touching items that previously touched the infectious rash or body fluids. The incubation period is usually 6 to 13 days. Diagnosis involves polymerase chain reaction testing, while treatment includes the antiviral tecovirimat and vaccines for smallpox may provide limited protection as both diseases are from the same family.
The document summarizes Nigeria's 2016 Lassa fever epidemic. It describes the epidemiology and transmission of Lassa virus, symptoms and treatment of Lassa fever, and the response efforts. Key points include: (1) Lassa fever is endemic in West Africa and causes annual outbreaks in Nigeria, with the multimammate mouse being the primary host; (2) person-to-person transmission can occur in hospitals lacking infection control; (3) the case fatality rate was 1% historically but rose to 34.31% in the 2016 Nigeria outbreak; (4) supportive care and ribavirin treatment improve survival rates.
Erysipelothrix rhusiopathiae infection in pigs, pork and raw pork handlers in...ILRI
Presentation by Angella Musewa, Kristina Roesel, Damalie Nakanjako, Delia Grace, Ronald Ssenyonga, Joan Nangendo, Ismael Kawooya, Joseph Erume at the first joint conference of the Association of Institutions for Tropical Veterinary Medicine and the Society of Tropical Veterinary Medicine, Berlin, Germany, 4–8 September 2016.
This document discusses brucellosis, a zoonotic disease caused by bacteria of the genus Brucella. It primarily affects livestock such as cattle, goats, and pigs. The disease can be transmitted to humans through consumption of unpasteurized dairy products or contact with infected animals/tissues. Clinical features in humans include undulant fever and nonspecific symptoms affecting multiple organ systems. Diagnosis involves serological tests or culture of blood/tissues. Treatment consists of a combination of doxycycline and streptomycin or rifampin over several weeks. Prevention focuses on vaccination of livestock and avoiding raw dairy products.
Rhabdoviridae is a family of viruses that includes over 150 members, with rabies virus being the most important human pathogen. Rabies virus has a bullet-shaped structure with a linear, negative-sense single stranded RNA genome encapsulated by a nucleoprotein and surrounded by a lipid envelope containing glycoprotein spikes. Rabies virus is typically transmitted through the bite or scratch of an infected animal and causes fatal neurological disease in humans. While treatment after symptoms is ineffective, vaccination can prevent disease if administered promptly after exposure.
Adenovirus belongs to the family Adenoviridae
This is a double stranded DNA virus
Does not possess an envelope
Adenovirus is icosahedral in shape
Thus not easily destroyed
It’s name is given as this virus is first isolated from the add noise
But this virus can affect several systems and cause several illnesses
Adenovirus affects respiratory system, gastrointestinal system, genitourinary system and the eye
So this virus has many serotypes
This document provides information on various paramyxoviruses, including parainfluenza virus, mumps virus, measles virus, and respiratory syncytial virus (RSV). It describes their morphology, genome, taxonomy, pathogenesis, transmission, symptoms, complications, diagnosis, and treatment. The paramyxoviruses are enveloped viruses that contain single-stranded, negative-sense RNA genomes. They cause a variety of respiratory illnesses in humans and animals. Laboratory diagnosis involves antigen detection, virus isolation, serology, and molecular techniques like RT-PCR. Vaccines are available to prevent infections from some paramyxoviruses.
Adenoviruses are non-enveloped double stranded DNA viruses that are isolated from adenoid tissue. They cause respiratory, eye, urinary tract and intestinal infections in children and military recruits. There are over 50 serotypes classified into groups A through F. Symptoms vary depending on the infected site and serotype but include respiratory diseases, sore throat, follicular conjunctivitis and epidemic keratoconjunctivitis. Diagnosis involves tissue culture, complement fixation tests, PCR and electron microscopy. While there is no vaccine for general use, some vaccines exist to control outbreaks in closed communities.
Monkeypox is caused by an enveloped double-stranded DNA virus in the orthopoxvirus genus of the Poxviridae family. It can spread through direct contact with infectious rash, scabs, or body fluids, respiratory secretions during prolonged face-to-face contact, or touching items that previously touched the infectious rash or body fluids. The incubation period is usually 6 to 13 days. Diagnosis involves polymerase chain reaction testing, while treatment includes the antiviral tecovirimat and vaccines for smallpox may provide limited protection as both diseases are from the same family.
The document summarizes Nigeria's 2016 Lassa fever epidemic. It describes the epidemiology and transmission of Lassa virus, symptoms and treatment of Lassa fever, and the response efforts. Key points include: (1) Lassa fever is endemic in West Africa and causes annual outbreaks in Nigeria, with the multimammate mouse being the primary host; (2) person-to-person transmission can occur in hospitals lacking infection control; (3) the case fatality rate was 1% historically but rose to 34.31% in the 2016 Nigeria outbreak; (4) supportive care and ribavirin treatment improve survival rates.
This document summarizes information about the vesiculovirus family, which includes rabies virus. It describes the bullet-shaped, enveloped structure of vesiculoviruses with glycoprotein spikes. The major antigenic factor is glycoprotein G, which is responsible for neuroinvasiveness. Vesiculoviruses can infect all warm-blooded animals and are transmitted via bites. In humans, rabies causes an incubation period of weeks to years followed by an acute neurological phase and death if not treated. Diagnosis involves antigen detection, viral isolation, and antibody detection by various tests including RT-PCR and histopathological staining for Negri bodies.
Rhino virus, corona virus, and enterovirus are common causes of respiratory illness. Rhino virus is the main cause of the common cold and symptoms typically resolve within a week. Corona viruses can cause mild upper respiratory infections or more severe illness like SARS. Enteroviruses are transmitted through oral contact and cause a variety of respiratory symptoms from sore throat to pneumonia. Treatment is usually supportive and prevention focuses on hand hygiene and sanitation.
Rabies is a fatal viral infection of the central nervous system that is transmitted through the bites of infected animals. The rabies virus causes either an encephalitic or paralytic form of disease in humans. Prodromal symptoms are non-specific but may include pain or tingling near the site of exposure. The encephalitic form leads to symptoms like hydrophobia and aerophobia, while the paralytic form causes muscle weakness. Diagnosis involves detecting viral antibodies, RNA, or inclusions in brain tissue. There is no cure once symptoms begin, but rabies can be prevented through prompt post-exposure prophylaxis including wound cleaning and vaccination.
This document provides information on the adenovirus. It discusses that adenoviruses can cause respiratory, gastrointestinal, and urinary tract infections as well as eye infections. It describes the morphology of adenoviruses including their icosahedral capsids. It covers the classification of adenoviruses into genera, species, and human serotypes. It discusses the pathogenesis of adenovirus infections and associated clinical manifestations like respiratory diseases, eye infections, and gastrointestinal diseases. It also outlines methods for laboratory diagnosis including isolation, serology, and molecular techniques. Treatment involves supportive care as there is no specific antiviral.
For the students studying Medical Microbiology like MSC BSC MBBS DENTAL BPTH Nursing DMLT Pharmacy etc and also for those who are preparing for exams such as NEET
Rhabdoviruses are enveloped viruses that contain single-stranded RNA. They have a bullet-shaped appearance and include important genera like Vesiculovirus and Lyssavirus. The Rabies virus is a notable Rhabdovirus that causes fatal encephalitis in humans and other mammals. Rhabdoviruses are resistant to lipid solvents and inactivated by treatments like phenol, heat, and sunlight.
RhabdoVirus is a single stranded, linear, negative sense, non-segmented RNA virus that is enveloped and bullet shaped. It multiplies in the cytoplasm. Rabies virus is an example. Rabies virus enters through bites from rabid animals and is carried in the saliva, depositing at the wound site. If untreated, 50% of those exposed will develop rabies as the virus multiplies in muscles, connective tissue and nerves before infecting the central nervous system. Symptoms include headache, fever, sore throat, nervousness, confusion, pain or tingling at the bite site, hallucinations, hydrophobia, paralysis, and eventually coma and death. Diagnosis involves antigen detection
Rhabdoviruses include the genus Lyssavirus, which contains rabies virus. Rabies virus is bullet-shaped with glycoprotein spikes and surrounds its single-stranded RNA. It infects humans and warm-blooded animals via bites. After incubation, patients experience prodromal fever and malaise followed by neurological symptoms like hydrophobia and paralysis. Diagnosis involves detecting viral antigens, RNA, or antibodies. There is no cure for rabies so prevention focuses on rapid post-exposure prophylaxis including wound cleansing, rabies immunoglobulin, and rabies vaccines.
Hantaviruses are RNA viruses that can cause diseases like Hantavirus Pulmonary Syndrome (HPS). HPS was first diagnosed in the US in 1993 in the Four Corners region of the Southwest. It is a lung infection caused by viruses in rodent droppings and urine. Symptoms include fever, fatigue, and muscle aches initially, followed later by coughing and shortness of breath. Transmission occurs through inhaling aerosolized virus from rodent excreta. There is no vaccine and treatment is supportive only.
This document discusses rhabdoviruses, specifically rabies virus. It describes rhabdoviruses as bullet-shaped, enveloped viruses with negative-sense RNA genomes. Rabies virus causes rabies disease in mammals via transmission through bites from infected animals. After an incubation period, the virus spreads from the site of infection to the central nervous system, causing fatal neurological symptoms. Vaccination of pets and post-exposure prophylaxis including vaccination are effective control measures for rabies.
EPIZOOTIC LYMPHANGITIS is a chronic, contagious fungal disease that affects horses, donkeys, and mules. It is characterized by suppurative lymphangitis, lymphadenitis, and skin ulcers. The causative agent is the fungus Histoplasma farciminosum. The disease spreads through direct contact with infected animals or contact with contaminated soil or flies. Clinical signs include spreading skin lesions and lymphangitis along the limbs. Diagnosis involves identifying the fungus microscopically or through culture. Treatment has limited success. Control relies on identifying and destroying infected animals, quarantining other animals, and disinfecting equipment.
The rhinovirus (from the Greek ῥίς rhis "nose", gen ῥινός rhinos "of the nose", and the Latin vīrus) is the most common viral infectious agent in humans and is the predominant cause of the common cold. Rhinovirus infection proliferates in temperatures of 33–35 °C (91–95 °F), the temperatures found in the nose. Rhinoviruses belong to the genus Enterovirus in the family Picornaviridae.
The three species of rhinovirus (A, B, and C) include around 160 recognized types of human rhinovirus that differ according to their surface proteins (serotypes).[1] They are lytic in nature and are among the smallest viruses, with diameters of about 30 nanometers. By comparison, other viruses, such as smallpox and vaccinia, are around ten times larger at about 300 nanometers; while flu viruses are around 80–120 nm.
Herpesviruses are enveloped viruses that contain double-stranded DNA. They can establish latent or persistent infections following primary infection. There are three subfamilies of herpesviruses - Alphaherpesvirinae, Betaherpesvirinae, and Gammaherpesvirinae - which differ in their growth characteristics and sites of latency. Primary infections and reactivations are more serious in immunocompromised patients. Common human herpesviruses include HSV-1, HSV-2, VZV, EBV, CMV, HHV-6, HHV-7, and HHV-8, which cause diseases like cold sores, chickenpox, mononucleosis, and some cancers
Lassa fever is a viral hemorrhagic illness transmitted to humans through contact with the urine or feces of infected Mastomys rats. It is endemic in parts of West Africa, with 100,000-300,000 infections estimated annually. Symptoms can include bleeding, abdominal pain, and fever. Treatment involves supportive care and the antiviral ribavirin if given early. Prevention focuses on proper food storage, hygiene practices, and rodent control to avoid exposure to infected rats.
A PRESENTATION DESCRIPS RESPERATORY INFECTIONS CAUSED BY RSV AND PATHOGENESIS , DIAGNOSIS , TREATMENT, VACCINATION,STRUCTRUE AND LIFE CYCLE OF THIS VIRUS
Viral hemorrhagic fevers are caused by RNA viruses from several families including Arenaviridae, Bunyaviridae, Filoviridae, and Flaviviridae. They cause severe illness characterized by fever and bleeding and can be lethal. Transmission varies between rodents, ticks, and mosquitoes depending on the virus. Symptoms typically appear 2-16 days after exposure and include fever, malaise, and bleeding from various orifices. Treatment is largely supportive though ribavirin may be effective for some viruses. Strict isolation of patients and notification of authorities is required.
Parvovirus is a small, single-stranded DNA virus that causes diseases like fifth disease and aplastic anemia. It is around 22 nm in diameter with an icosahedral capsid but no envelope. Symptoms of parvovirus infection include fever, chills, and a bright red, raised "slap cheek" rash on the face and lacy rash on the extremities. Treatment focuses on supportive care with ibuprofen for fever as a vaccine remains in trials.
This document discusses the nature and properties of viruses. It defines viruses as obligate intracellular parasites that consist of nucleic acid genomes enclosed in protein capsids. Viruses can have DNA or RNA genomes, and they require host cells to replicate as they lack their own metabolic machinery. The document outlines the virus replication cycle and explains how viruses enter cells, express their genes, replicate their genomes, and assemble new virus particles. It also discusses why viruses are important to study due to their ability to cause diseases in humans, animals and plants.
Infectious Laryngotracheitis, ILT symptoms in ChickensField Vet
Infectious laryngotracheitis (ILT) is an acute, highly contagious, herpesvirus infection of chickens and pheasants characterized by severe dyspnea, coughing, and rales. In the acute form, gasping, coughing, rattling, and extension of the neck during inspiration are seen 5–12 days after natural exposure. Reduced productivity is a varying factor in laying flocks. Affected birds are anorectic and inactive. The mouth and beak may be bloodstained from the tracheal exudate.
Neurological and Autoimmune Complications of Zika Virus infection - Slideset ...WAidid
The slideset by Professor Safadi analyses the case control study providing evidence for Zika virus infection causing Guillain-Barré syndrome.
In addition to Zika Virus association with Guillain-Barré syndrome, the slides show new data from endemic areas suggesting that ZIKV may be linked to other neurological outcomes.
This document provides an overview of enteroviruses, including their properties, clinical aspects, pathogenesis, treatment and epidemiology. It describes enteroviruses as common human pathogens that usually cause mild fever but can rarely lead to severe disease. Key points include that enteroviruses are small, non-enveloped viruses that replicate in the cytoplasm and can cause illnesses like aseptic meningitis, hand foot and mouth disease, and herpangina. While good hygiene helps prevent transmission, there are currently no vaccines or specific antiviral treatments.
This document summarizes information about the vesiculovirus family, which includes rabies virus. It describes the bullet-shaped, enveloped structure of vesiculoviruses with glycoprotein spikes. The major antigenic factor is glycoprotein G, which is responsible for neuroinvasiveness. Vesiculoviruses can infect all warm-blooded animals and are transmitted via bites. In humans, rabies causes an incubation period of weeks to years followed by an acute neurological phase and death if not treated. Diagnosis involves antigen detection, viral isolation, and antibody detection by various tests including RT-PCR and histopathological staining for Negri bodies.
Rhino virus, corona virus, and enterovirus are common causes of respiratory illness. Rhino virus is the main cause of the common cold and symptoms typically resolve within a week. Corona viruses can cause mild upper respiratory infections or more severe illness like SARS. Enteroviruses are transmitted through oral contact and cause a variety of respiratory symptoms from sore throat to pneumonia. Treatment is usually supportive and prevention focuses on hand hygiene and sanitation.
Rabies is a fatal viral infection of the central nervous system that is transmitted through the bites of infected animals. The rabies virus causes either an encephalitic or paralytic form of disease in humans. Prodromal symptoms are non-specific but may include pain or tingling near the site of exposure. The encephalitic form leads to symptoms like hydrophobia and aerophobia, while the paralytic form causes muscle weakness. Diagnosis involves detecting viral antibodies, RNA, or inclusions in brain tissue. There is no cure once symptoms begin, but rabies can be prevented through prompt post-exposure prophylaxis including wound cleaning and vaccination.
This document provides information on the adenovirus. It discusses that adenoviruses can cause respiratory, gastrointestinal, and urinary tract infections as well as eye infections. It describes the morphology of adenoviruses including their icosahedral capsids. It covers the classification of adenoviruses into genera, species, and human serotypes. It discusses the pathogenesis of adenovirus infections and associated clinical manifestations like respiratory diseases, eye infections, and gastrointestinal diseases. It also outlines methods for laboratory diagnosis including isolation, serology, and molecular techniques. Treatment involves supportive care as there is no specific antiviral.
For the students studying Medical Microbiology like MSC BSC MBBS DENTAL BPTH Nursing DMLT Pharmacy etc and also for those who are preparing for exams such as NEET
Rhabdoviruses are enveloped viruses that contain single-stranded RNA. They have a bullet-shaped appearance and include important genera like Vesiculovirus and Lyssavirus. The Rabies virus is a notable Rhabdovirus that causes fatal encephalitis in humans and other mammals. Rhabdoviruses are resistant to lipid solvents and inactivated by treatments like phenol, heat, and sunlight.
RhabdoVirus is a single stranded, linear, negative sense, non-segmented RNA virus that is enveloped and bullet shaped. It multiplies in the cytoplasm. Rabies virus is an example. Rabies virus enters through bites from rabid animals and is carried in the saliva, depositing at the wound site. If untreated, 50% of those exposed will develop rabies as the virus multiplies in muscles, connective tissue and nerves before infecting the central nervous system. Symptoms include headache, fever, sore throat, nervousness, confusion, pain or tingling at the bite site, hallucinations, hydrophobia, paralysis, and eventually coma and death. Diagnosis involves antigen detection
Rhabdoviruses include the genus Lyssavirus, which contains rabies virus. Rabies virus is bullet-shaped with glycoprotein spikes and surrounds its single-stranded RNA. It infects humans and warm-blooded animals via bites. After incubation, patients experience prodromal fever and malaise followed by neurological symptoms like hydrophobia and paralysis. Diagnosis involves detecting viral antigens, RNA, or antibodies. There is no cure for rabies so prevention focuses on rapid post-exposure prophylaxis including wound cleansing, rabies immunoglobulin, and rabies vaccines.
Hantaviruses are RNA viruses that can cause diseases like Hantavirus Pulmonary Syndrome (HPS). HPS was first diagnosed in the US in 1993 in the Four Corners region of the Southwest. It is a lung infection caused by viruses in rodent droppings and urine. Symptoms include fever, fatigue, and muscle aches initially, followed later by coughing and shortness of breath. Transmission occurs through inhaling aerosolized virus from rodent excreta. There is no vaccine and treatment is supportive only.
This document discusses rhabdoviruses, specifically rabies virus. It describes rhabdoviruses as bullet-shaped, enveloped viruses with negative-sense RNA genomes. Rabies virus causes rabies disease in mammals via transmission through bites from infected animals. After an incubation period, the virus spreads from the site of infection to the central nervous system, causing fatal neurological symptoms. Vaccination of pets and post-exposure prophylaxis including vaccination are effective control measures for rabies.
EPIZOOTIC LYMPHANGITIS is a chronic, contagious fungal disease that affects horses, donkeys, and mules. It is characterized by suppurative lymphangitis, lymphadenitis, and skin ulcers. The causative agent is the fungus Histoplasma farciminosum. The disease spreads through direct contact with infected animals or contact with contaminated soil or flies. Clinical signs include spreading skin lesions and lymphangitis along the limbs. Diagnosis involves identifying the fungus microscopically or through culture. Treatment has limited success. Control relies on identifying and destroying infected animals, quarantining other animals, and disinfecting equipment.
The rhinovirus (from the Greek ῥίς rhis "nose", gen ῥινός rhinos "of the nose", and the Latin vīrus) is the most common viral infectious agent in humans and is the predominant cause of the common cold. Rhinovirus infection proliferates in temperatures of 33–35 °C (91–95 °F), the temperatures found in the nose. Rhinoviruses belong to the genus Enterovirus in the family Picornaviridae.
The three species of rhinovirus (A, B, and C) include around 160 recognized types of human rhinovirus that differ according to their surface proteins (serotypes).[1] They are lytic in nature and are among the smallest viruses, with diameters of about 30 nanometers. By comparison, other viruses, such as smallpox and vaccinia, are around ten times larger at about 300 nanometers; while flu viruses are around 80–120 nm.
Herpesviruses are enveloped viruses that contain double-stranded DNA. They can establish latent or persistent infections following primary infection. There are three subfamilies of herpesviruses - Alphaherpesvirinae, Betaherpesvirinae, and Gammaherpesvirinae - which differ in their growth characteristics and sites of latency. Primary infections and reactivations are more serious in immunocompromised patients. Common human herpesviruses include HSV-1, HSV-2, VZV, EBV, CMV, HHV-6, HHV-7, and HHV-8, which cause diseases like cold sores, chickenpox, mononucleosis, and some cancers
Lassa fever is a viral hemorrhagic illness transmitted to humans through contact with the urine or feces of infected Mastomys rats. It is endemic in parts of West Africa, with 100,000-300,000 infections estimated annually. Symptoms can include bleeding, abdominal pain, and fever. Treatment involves supportive care and the antiviral ribavirin if given early. Prevention focuses on proper food storage, hygiene practices, and rodent control to avoid exposure to infected rats.
A PRESENTATION DESCRIPS RESPERATORY INFECTIONS CAUSED BY RSV AND PATHOGENESIS , DIAGNOSIS , TREATMENT, VACCINATION,STRUCTRUE AND LIFE CYCLE OF THIS VIRUS
Viral hemorrhagic fevers are caused by RNA viruses from several families including Arenaviridae, Bunyaviridae, Filoviridae, and Flaviviridae. They cause severe illness characterized by fever and bleeding and can be lethal. Transmission varies between rodents, ticks, and mosquitoes depending on the virus. Symptoms typically appear 2-16 days after exposure and include fever, malaise, and bleeding from various orifices. Treatment is largely supportive though ribavirin may be effective for some viruses. Strict isolation of patients and notification of authorities is required.
Parvovirus is a small, single-stranded DNA virus that causes diseases like fifth disease and aplastic anemia. It is around 22 nm in diameter with an icosahedral capsid but no envelope. Symptoms of parvovirus infection include fever, chills, and a bright red, raised "slap cheek" rash on the face and lacy rash on the extremities. Treatment focuses on supportive care with ibuprofen for fever as a vaccine remains in trials.
This document discusses the nature and properties of viruses. It defines viruses as obligate intracellular parasites that consist of nucleic acid genomes enclosed in protein capsids. Viruses can have DNA or RNA genomes, and they require host cells to replicate as they lack their own metabolic machinery. The document outlines the virus replication cycle and explains how viruses enter cells, express their genes, replicate their genomes, and assemble new virus particles. It also discusses why viruses are important to study due to their ability to cause diseases in humans, animals and plants.
Infectious Laryngotracheitis, ILT symptoms in ChickensField Vet
Infectious laryngotracheitis (ILT) is an acute, highly contagious, herpesvirus infection of chickens and pheasants characterized by severe dyspnea, coughing, and rales. In the acute form, gasping, coughing, rattling, and extension of the neck during inspiration are seen 5–12 days after natural exposure. Reduced productivity is a varying factor in laying flocks. Affected birds are anorectic and inactive. The mouth and beak may be bloodstained from the tracheal exudate.
Neurological and Autoimmune Complications of Zika Virus infection - Slideset ...WAidid
The slideset by Professor Safadi analyses the case control study providing evidence for Zika virus infection causing Guillain-Barré syndrome.
In addition to Zika Virus association with Guillain-Barré syndrome, the slides show new data from endemic areas suggesting that ZIKV may be linked to other neurological outcomes.
This document provides an overview of enteroviruses, including their properties, clinical aspects, pathogenesis, treatment and epidemiology. It describes enteroviruses as common human pathogens that usually cause mild fever but can rarely lead to severe disease. Key points include that enteroviruses are small, non-enveloped viruses that replicate in the cytoplasm and can cause illnesses like aseptic meningitis, hand foot and mouth disease, and herpangina. While good hygiene helps prevent transmission, there are currently no vaccines or specific antiviral treatments.
Driving Success in Automotive - JDA Software and AccentureJDA Software
While most automotive OEMs and their supplier tiers are
struggling to reconcile their old ways of doing business with the
“new normal” economy, there is good news for those companies
willing to innovate and adapt their production models.
The Facts on Enterovirus d-68 a respiratory virus affecting childrenpremier1er
“While Ebola has received the most media attention since the diagnosis at a Dallas hospital, EV-D68 (enterovirus) potentially poses a more pressing health risk to people in the U.S. because it is easier to spread,” said Marco Coppola, DO, FACEP, Chief Medical Officer of Premier One Emergency Centers.
This document summarizes a presentation given by Krisandra Allen on an outbreak of hand, foot, and mouth disease (HFMD) that occurred across multiple colleges in Virginia in 2012. The outbreak involved over 60 reported cases of HFMD at College A, University B, and University C between September and October 2012. Laboratory testing identified Coxsackievirus A6 as the cause of illness in samples collected from students at University B. The outbreak highlighted HFMD as an emerging disease that can affect college-aged populations. Recommendations were provided to the colleges to control transmission and prevent future outbreaks.
Enteroviruses are common human pathogens found worldwide that usually cause mild fever but can rarely lead to severe disease. They are small, non-enveloped viruses with RNA genomes that infect through endocytosis and replicate in the cytoplasm before causing cell lysis. While often asymptomatic, they can cause rash, fever, muscle aches and other flu-like symptoms. Though no vaccine exists, treatment focuses on symptom relief and good hygiene to prevent transmission through bodily fluids. Major diseases include aseptic meningitis and hand, foot, and mouth disease.
The document discusses viral exanthems, providing definitions and describing common viral exanthems that present with rashes in children including roseola, erythema infectiosum, and hand-foot-and-mouth disease. It also discusses nonspecific viral exanthems which are more common and difficult to diagnose based on their generalized rash presentation and lack of distinctive features. The document aims to help medical students develop a clinical approach to evaluating and managing patients presenting with typical viral rashes.
The document discusses picornaviruses, a family of small RNA viruses that includes enteroviruses. It provides details on the structure, classification, and diseases caused by different genera of picornaviruses, with a focus on enteroviruses and polioviruses. Key points covered include the icosahedral structure of picornaviruses; classification of enteroviruses into different genera; diseases caused by different enteroviruses including poliomyelitis caused by polioviruses; laboratory diagnosis of enteroviral infections; and prevention of poliomyelitis through vaccines.
Este documento describe la familia Picornaviridae, que incluye los géneros Enterovirus, Rinovirus, Heparnavirus y Aphtovirus. Se enfoca en el género Enterovirus, describiendo su estructura, multiplicación, patogenicidad, epidemiología y diagnóstico. También cubre brevemente el virus de la poliomielitis, uno de los enterovirus más importantes.
- Zika virus is an emerging mosquito-borne virus first identified in 1947 in Uganda. It spread widely in 2015-2016 throughout South and Central America and the Caribbean.
- It is transmitted primarily via the bite of infected Aedes mosquitoes. While most cases are asymptomatic, it can cause mild fever and rash. A major concern is its link to microcephaly in babies born to infected mothers.
- There is no vaccine or treatment. Prevention focuses on avoiding mosquito bites through protective clothing and repellents, especially for pregnant women considering travel to outbreak areas.
Picornavirus is a family of viruses that includes poliovirus and hepatitis A virus. It has a simple structure without an envelope and causes diseases like poliomyelitis and hepatitis A. Currently there are no specific antiviral treatments available for picornavirus infections like poliovirus and hepatitis A virus, though symptoms can be treated and prevention focuses on vaccination.
Los enterovirus son un grupo de virus ARN que incluyen poliovirus, coxsackievirus y virus ECHO. Causan una variedad de enfermedades como poliomielitis, meningitis, miocarditis y erupciones cutáneas. Se transmiten fácilmente de persona a persona a través de las heces y secreciones respiratorias. La mayoría de las infecciones son asintomáticas o leves, pero algunos tipos pueden causar enfermedades graves, especialmente en niños. No existen vacunas para la mayoría de los enterovirus, a
This presentation is on basic virology on Enterovirus diseases. Viruses includes Coxsackie virus, entero virus 71, rota virus, polio virus. Slides are suitable for medical students and medical graduate.
Este documento resume las características de los enterovirus, una familia de virus ARN que incluye al poliovirus y otros virus causantes de enfermedades como la meningitis, la miocarditis y la enfermedad mano-pie-boca. Los enterovirus son pequeños, sin envoltura, resistentes y se transmiten fecal-oral. Incluyen más de 70 serotipos que infectan al tracto gastrointestinal y respiratorio superior del hombre, causando una variedad de enfermedades agudas.
Este documento describe la familia Picornaviridae, que incluye los géneros Enterovirus, Rinovirus, Heparnavirus y Aphtovirus. Se enfoca en el género Enterovirus, discutiendo su estructura, multiplicación, patogenicidad, epidemiología y prevención. Menciona que son virus pequeños con ARN sin envuelta que infectan el tracto respiratorio e intestinal y se transmiten por la vía fecal-oral.
El documento describe la familia Picornaviridae, que incluye enterovirus como el poliovirus. Son virus ARN no segmentados con cápside icosaédrica de 20-30 nm que se replican óptimamente a 37°C. Se transmiten por vía fecal-oral y son resistentes al medio ambiente. Causan varias enfermedades como la poliomielitis, meningitis y miocarditis. La poliomielitis puede causar parálisis y es causada por los serotipos 1, 2 y 3 del poliovirus. Existen vacunas inactivadas
Picornaviruses are a family of small RNA viruses that includes enteroviruses like poliovirus and rhinoviruses that cause the common cold. They are spherical and non-enveloped, around 30nm in diameter, and contain a single strand of positive-sense RNA genome around 7-8kb in size. Picornaviruses infect the cytoplasm and their replication results in cell lysis and spread to other cells. Important human pathogens include the polioviruses, coxsackieviruses, echoviruses and rhinoviruses. Both live attenuated and inactivated vaccines have been developed to prevent diseases like polio.
Picornaviruses are a large family of small viruses that include important human pathogens like enteroviruses and rhinoviruses. They cause a wide range of diseases from mild illnesses to paralysis. Poliovirus can cause paralytic poliomyelitis. Coxsackieviruses can cause herpangina, hand-foot-and-mouth disease, myocarditis, and meningitis. Vaccines have largely eradicated polio in most countries.
1. Direct fluorescent antibody staining of cells from a herpes simplex lesion can detect fluorescent infected cells under a fluorescence microscope, providing a more sensitive and specific method of diagnosis than a Tzanck prep.
2. Enzyme immunoassays are often used to detect non-culturable viruses like rotavirus, influenza, and respiratory syncytial virus from nasal/NP swabs at the point-of-care.
3. Molecular amplification tests exceed the sensitivity of viral culture and are the gold standard for diagnosing many respiratory viruses, herpes simplex from CSF, and enterovirus detection.
This document provides an overview of Hepatitis E virus (HEV) and discusses several key points:
1. HEV is a major health issue in developing countries where it causes large outbreaks and high mortality rates in pregnant women. Genotypes 1 and 2 are prevalent in these regions.
2. HEV genotype 3 is now recognized as an important cause of acute and chronic hepatitis in developed countries. It is the most common cause of acute hepatitis in older adults in some regions.
3. HEV infection is often asymptomatic but can cause a range of clinical manifestations from mild hepatitis to liver failure. Chronic infection can develop in transplant patients.
4. HEV is estimated to cause 20 million infections globally
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Amanda Mocroft, UCL
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Multisystem inflammatory syndrome in children and adolescents with COVID-19Chaitanya Nukala
Multisystem Inflammatory Syndrome in children (MIS-C) OR
Pediatric Multisystem Inflammatory Syndrome [PMIS] OR
pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 [PIMS-TS], OR
pediatric hyper inflammatory syndrome, or pediatric hyper inflammatory shock) OR
KAWA-COVID
High Sensitivity HIV Testing and Translational Science around PrEPHopkinsCFAR
Joanne Stekler, MD MPH
Associate Professor, Department of Medicine
University of Washington
Inter-Center for AIDS ResearchAntiretroviralsfor Prevention Working Group
November 13, 2017
This document discusses HIV and hepatitis C, and how treatment has improved outcomes. It presents two case studies of patients with advanced HIV presenting with opportunistic infections who were successfully treated. It also summarizes research showing that early antiretroviral therapy improves survival for patients with HIV/AIDS or opportunistic infections like PCP, and that cure of hepatitis C through direct-acting antivirals reduces mortality and complications like liver cancer. While treatment access has increased globally, challenges remain in testing and treating all those in need.
This document summarizes the monthly clinical audit activities of the internal medicine department at HFSUH for the month of Sene 2015 E.C. It provides data on outpatient department activities including the regular OPD, MRC, neurology clinic, TB clinic, and ART clinic. It also summarizes inpatient activities in the male/female wards, neurology ward, ICU, and intermediate care ward. Key findings included increased OPD volume, improved chronic case linkage, and decreased number of patients leaving against medical advice. Gaps identified were inadequate equipment and staffing, incomplete documentation, and issues with radiology and laboratory services.
Keystone ECMO meeting 2018: To review the characteristics and outcomes of pediatric patients with viral pneumonia placed on ECMO whose data were entered into the Extracorporeal Life Support Organization (ELSO) registry.
Presentation from the 3rd Joint Meeting of the Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Networks, organised by the European Centre of Disease Prevention and Control - Stockholm, 11-13 February 2015
The document discusses World AIDS Day which is held annually on December 1st to raise awareness about HIV/AIDS and show support for those living with the disease. It provides information about the themes, transmission, stages of HIV infection, testing, and treatment. The document also outlines the goals of increasing HIV testing and treatment to work towards eliminating HIV/AIDS by 2030.
HEV can be transmitted through blood transfusions. Several cases have been reported in Europe and Japan of HEV transmission through blood products. While notification of HEV cases is mandatory in some countries, few countries have implemented mandatory testing of blood donations for HEV. Only Luxembourg tests all plasma donations for HEV RNA. Some countries have taken interim measures like testing donations to obtain prevalence data or using HEV-free plasma for high risk patients. Most countries do not currently have plans for national measures but some are exploring initiatives for gathering prevalence data or testing high risk donor groups.
This document summarizes laboratory diagnosis of COVID-19. It discusses that molecular (rRT-PCR) tests target genes like E, RdRp, N, and ORF 1ab. Specimens collected include nasopharyngeal swabs, oropharyngeal swabs, sputum, and stool. Interpretation of rRT-PCR tests follows WHO and CDC guidelines. Serological tests detect IgM and IgG antibodies but are not recommended for diagnosis. Viral sequencing and culture are also discussed. Abnormal lab findings in COVID-19 patients include decreased lymphocytes and albumin and increased LDH, D-dimer and inflammatory markers.
This study analyzed data from 80,642 HIV-infected adults in European cohorts to compare mortality rates to the general population. The overall mortality rate was 1.2/100 person-years, 4.2 times higher than the general population. Among those with a CD4 count over 500/mm3, the mortality rate was similar to the general population for non-injection drug using men and women after 3 years. Mortality rates remained elevated for injection drug users, though decreased with longer durations of high CD4 counts. A prior AIDS diagnosis was associated with higher mortality, underlining the importance of early HIV diagnosis.
1st Hepatitis E virus expert meeting at ECDC, IntroductionCornelia Adlhoch
The expert group meeting discussed hepatitis E virus (HEV) epidemiology, surveillance, and risks in the EU/EEA. HEV is an under-surveilled cause of hepatitis worldwide with different genotypes infecting people. While most EU cases were previously travel-related, HEV genotype 3 is now endemic in Europe with an animal reservoir. Surveillance varies between countries with no EU-wide system. The group aims to inventory HEV in Europe by surveying countries on surveillance methods and collecting case numbers to describe epidemiology and populations at risk. This will identify needs for EU guidance on diagnosis, risk assessment, and prevention strategies to respond to HEV health threats.
Objectives:
1.To review the latest updates in the Canadian VAP Guidelines
2.To highlight the changes and why these changes are important
Read more and watch the recorded webinar: http://bit.ly/1sRCowQ
Sickle Cell Disease: Newborn screening in France and the UK - Jacques ElionHuman Variome Project
This document discusses the comprehensive care programs for sickle cell disease (SCD) in the United Kingdom and France. It describes the establishment of newborn screening programs for SCD in both countries in the late 1980s/early 2000s. It also outlines national registries, specialized treatment centers, and clinical standards/guidelines that have been implemented to improve care for SCD patients. The document analyzes outcomes data from these programs, showing improvements in early diagnosis, treatment, and survival for children with SCD.
The document provides an overview of the Integrated Disease Surveillance Programme (IDSP) in Tamil Nadu. It describes the objectives of early detection and response to outbreaks. It outlines the organizational structure at the state and district levels. It defines disease surveillance and the difference between active and passive surveillance. It lists the diseases under surveillance in IDSP and the different reporting forms used in weekly reporting. It also discusses outbreak reporting, the roles of different departments, confirming and investigating outbreaks, case definitions, descriptive epidemiology, and the purpose of outbreak investigations.
This document provides an overview of the epidemiology of HIV/AIDS. It discusses the history and microbiology of HIV, global and national statistics on prevalence, risk groups in India, modes of transmission, clinical manifestations, diagnosis and treatment. Key points include: globally 38 million people are living with HIV, generalized epidemics exist where prevalence is over 1% in pregnant women, and high-risk groups in India include sex workers, injecting drug users, and men who have sex with men. Diagnosis involves antibody detection tests like ELISA and confirmation with Western blot. Progression is monitored using CD4 counts and viral load levels, with opportunistic infections occurring at different CD4 thresholds.
Similar to Enterovirus D68: an underestimated pathogen - Prof. Niesters (20)
Designing vaccines for specific populations and germs - Slides by Professor E...WAidid
The presentation given by Professor Susanna Esposito at ECCMID 2019. A view on vaccines recommendations, combined vaccinations and impact of vaccination practices in the eradication of major infectious diseases.
To learn more, please visit www.waidid.org
Influenza vaccination and prevention of antimicrobial resistance - Slides by ...WAidid
The lecture presented by Professor Susanna Esposito at AMR 2019 on influenza vaccination and abuse of available antimicrobials.
To learn more, please visit www.waidid.org.
POINT-of-IMPACT testing. A European perspective - Bert NiestersWAidid
This document discusses point-of-care and point-of-impact molecular diagnostic testing from a European perspective. It describes how molecular diagnostics is moving towards more commercial multiplex assays and automation. Near-patient testing provides results faster but challenges include defining quality indicators for new rapid assays and ensuring clinical relevance. Standards like ISO15189 and ISO22870 provide guidelines for quality control of centralized and decentralized testing. The changing regulatory landscape in Europe aims to improve safety and transparency for in vitro diagnostics.
Measles and its prevention - Slideset by professor EdwardsWAidid
In this study Professor Kathryn M. Edwards (Sarah H. Sell and Cornelius Vanderbilt Professor - Division of Pediatric Infectious Diseases - Vanderbilt University Medical Center) provides an update on measles and its prevention.
To learn more, please visit www.waidid.org!
Is the use of antibiotics necessary in the treatment of diarrhoea?WAidid
The document discusses the use of antibiotics in the treatment of diarrhea. It presents several case studies of children with diarrhea and asks participants to vote on whether they would prescribe antibiotics. It finds that antibiotics are often not necessary for treatment of diarrhea and can promote antibiotic resistance. Antibiotics may be useful for severe cases caused by certain pathogens like cholera or Shigella. The cornerstone of treatment is rehydration, while antibiotics should be reserved for targeted situations to avoid furthering the global crisis of antibiotic resistance.
Are we running out of antibiotics? - Slideset by Professor EspositoWAidid
How does antibiotic resistance happen?
This work, edited by the professor Susanna Esposito, tries to answer this question underlining the importance of prescribing the right drug with the right dose and duration, to avoid any kind of abuse that may cause or increase antibiotic resistance.
To learn more please visit www.waidid.org
Mandatory vaccinations: the italian experience - Slideset by Professor EspositoWAidid
Every year 2.5 million lives are saved by vaccines. In this slideset Professor Susanna Esposito gives an overview on the vaccine coverage in Italy, including the latest laws on mandatory and recommended vaccines.
To learn more please visit www.waidid.org
Efficacy differences between PCV10 and PCV13 - Slideset by Professors Esposit...WAidid
This slideset edited by Professors Esposito, Palmu, De Wals and Sanders for the Second WAidid Congress present some studies that compare in different countries (including Finland, Sweden, Quebec and the Netherlands) efficacy differences between PCV10 and PCV13.
To learn more please visit www.waidid.org
Efficacy and safety of immunomodulators in pediatric age - Slideset by Profes...WAidid
«The first cause of recurrent infections in children is... childhood itself.» (J. Gary Wheeler)
Is it possibe to treat and prevent recurrent respiratory infections (RTIs) in pediatric age? Some studies have shown that immunostimulants/immunomodulators can reduce and prevent RTIs in children.
To learn more please visit www.waidid.org
The importance of pertussis booster vaccine doses throughout life - Slideset ...WAidid
Pertussis is still a worldwide problem: every year there are almost 20-50 million cases and 300.000 deaths.
The incidence is increasing especially between adults and adolescents, with consequences on infants. For this reason, the increasing of a vaccination strategy for adolescent and adult is needed...
To learn more, please visit www.waidid.org.
Vaccination in immunosuppressed adults - Slideset by professor Katie FlanaganWAidid
1. Vaccination is important for immunosuppressed adults as they are at higher risk of infection from vaccine preventable diseases. Live vaccines should generally be avoided due to risk of infection, while inactivated vaccines are usually safe but may be less effective.
2. The degree and type of immunosuppression must be considered to determine the appropriate vaccination strategy. Those with conditions like cancer, HIV, organ transplants, and high dose corticosteroids may have limitations on live and inactivated vaccines.
3. Influenza vaccination is recommended annually for all immunosuppressed adults. Other common vaccines include pneumococcal, tetanus, hepatitis B, and human papillomavirus depending on the individual's
Potential advantages of booster containing PCV regimen - Professor Shabir MadhiWAidid
This slideset, realized by Professor Shabir Madhi on the occasion of the 11th ISPPD held in Melbourne last April, evaluates the potential advantages of booster containing PCV dosing schedule.
To learn more, visit www.waidid.org!
Considerations against the new shorter MDR-TB regimen - Prof. G. B. MiglioriWAidid
Este documento discute los límites del régimen acortado de tratamiento para la tuberculosis farmacorresistente y la importancia de realizar pruebas de sensibilidad a medicamentos antes del tratamiento. Analiza datos de cohortes en Europa y América Latina que muestran que menos del 12% de los pacientes con tuberculosis farmacorresistente son elegibles para el régimen acortado debido a la alta prevalencia de resistencia a medicamentos. Concluye que los tratamientos no deben prescribirse ciegamente sin pruebas de sensibilidad y que una gestión basada en
Group 5 drugs in the treatment of multidrug-resistant tuberculosis - Slideset...WAidid
Este documento discute la evidencia sobre el uso de fármacos del "grupo 5" en el tratamiento de la tuberculosis resistente en niños y adultos. Presenta algunos casos clínicos para ilustrar el uso de estos fármacos. Revisa la evidencia disponible sobre la eficacia y tolerabilidad de fármacos como delamanid, ethionamide, clofazimine, amikacin, linezolid y otros. También discute cuestiones abiertas como el uso combinado de delamanid y bedaquilina. Finalmente, presenta nueva evid
Lymphogranuloma venereum - Professor Ivan HungWAidid
In the following slides, professor Ivan Hung (WAidid board member) report a case of Lymphogranuloma Venereum and a short review of its possible source of infection, in order not to understimate the risk of infections, mainly in promiscuous behavioural context.
To learn more, visit www.waidid.org.
Bacterial and bacterial-like sepsis in children - Susanna Esposito WAidid
How to detect and prevent bacterial and bacterial-like sepsis in children and adolescents? Professor Susanna Esposito presents in this slideset data on epidemiology, etiology and mortality rates of pediatrical sepsis, and then discusses the possible treatment and the more efficient way of preventing the burden of pediatric sepsis.
To learn more, visit www.waidid.org.
Guidelines on the management of cystic fibrosis in the adult - Professor Fran...WAidid
1) Forecasts indicate the number of cystic fibrosis (CF) patients in Europe will increase by 50% by 2025, with the number of CF adults rising by 75% primarily due to children transitioning to adulthood.
2) Managing CF in adults requires consideration of transition from pediatric to adult care, treatment adherence, psychosocial support, late diagnoses, lung transplantation, and end-of-life care.
3) Adult CF care is best provided by pulmonologists in specialized centers treating a minimum of 100 patients, with patients reviewed regularly like every 2-3 months. Establishing accredited training and a core curriculum can help providers meet the evolving needs of adults with CF.
Katie Flanagan - Malaria vaccines current status and challengesWAidid
Vaccines are considered the most cost-effective means of control, prevention, elimination, eradication of infectious diseases: for this reason, a malaria vaccine would greatly assist in the drive to eradicate malaria from the world. Professor Flanagan presents in this slideset the current status and challenges of developing malaria vaccines.
To learn more, visit www.waidid.org!
New perspectives in the treatment of multidrug-resistant tuberculosis - Profe...WAidid
The slideset offers an overview of MDR-TB: the epidemiology, the efficacy of the available treatments, and the new perspectives in the management of the pathology.
The slideset underlines, moreover, the existence of a free cost online instrument developed by ERS together with WHO to help clinician from all Europe to manage difficult-to-treat TB cases: TB Consilium.
Indicators of acute otitis media severity - Prof. Tal MaromWAidid
The slideset of professor Marom investigates the possibility and ways to establish the severity of AOM and focuses on the differences between pneumococcal vs non-pneumococcal AOM.
FInd more on www.waidid.org
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Enterovirus D68: an underestimated pathogen - Prof. Niesters
1. Prof. dr. Bert Niesters
Department of Medical Microbiology
Division of Clinical of Virology
University Medical Center Groningen
The Netherlands
Division of Clinical Virology
Enterovirus D68
an underestimated pathogen
3. Division of Clinical Virology
What is enterovirus D68
• For the first time isolated in 1962
• From respiratory material
• Children with bronchiolitis, usually in the summer period
• Between 1970 and 2005, only 26 times reported
4. Division of Clinical Virology
Before 2010
• 2005 to 2010 reports from France, Philippines, USA, UK,
Netherlands, Japan…
• Mostly respiratory problems, bronchiolitis type illness
• Summer and early fall
5. Division of Clinical Virology
2010 Groningen
• Bronchiolitis-type illness
• Some severe cases requiring
intensive care treatment
• Many patients had underlying
condition
6. Division of Clinical Virology
Explaining illness: EV68
0
1
2
3
4
5
6
7
8
wk31 wk32 wk33 wk34 wk35 wk36 wk37 wk38 wk39 wk40 wk41
Week number (2010)
numberofpatients
August-November 2010: 24 patients with only dEV68 etection
‘RS-like illness’
In same period: peak in EV68 detections in sentinel surveillance system into
respiratory illness among patients seen by general practitioner; upsurge of EV68 in
USA, Japan and other countries worldwide
7. Division of Clinical Virology
Patients and clinical data
• 19 (79.2%) with underlying illness
• 14 (58.3%) related to pulmonary tract: hyperreactivity,
chronic oxygen need, lung transplantation
• median age 14 years (0-72 years)
• 41.7% under 2 years of age
• hospitalization in 23 patients (95.8%):
– median duration of hospitalization
5 days (1-25)
– ICU admission:
5 patients (20.8%)
• one without previous underlying illness
pneumonia
exacerbation
asthma/wheezing
upper respiratory
tract infection
8. Division of Clinical Virology
Patients and clinical data
• Hospitalization in 23 patients (95.8%):
– three hospital acquired infections
– median duration of illness at admission
3 days (0-10)
– median duration of hospitalization
5 days (1-25)
– ICU admission:
5 patients (20.8%)
• one without previous underlying illness
• need for mechanical ventilation
9. Division of Clinical Virology
Sequence analysis and phylogeny
• 24 patients in 2010, 4 patients in 2009
• based on VP4/VP2 sequence analysis: two distinct
phylogenetic clusters
– One with all 2009 and part of 2010 isolates
– One with only 2010 isolates
• VP1 partial sequencing: 3 nucleotide deletion in 2010
cluster
11. Labmicta, Enschede
Isala, Zwolle
Izore, Leeuwarden
UMCG
LvI
Apeldoorn
Dr. Donker, Prof. Grundmann, UMCG
UMCG
Regional Center
Satellite
Connectivity between regional centers
(does not cross borders)
12. Division of Clinical Virology
TYPENED and REGIOtype
• Sequencing of enterovirus,
parechovirus, rhinovirus and
norovirus in the region and in
real time
13. Division of Clinical Virology
Stockman et al. MMWR Weekly
Volume 60, No. 38
September 30, 2011
14. Division of Clinical Virology
After 2010
• Very few reported cases
• Many labs fail to detect EV-
D68 in quality assurance
panels
• No EV-D68 specific test
• Not all rhinovirus PCRs pick
up EV-D68
• Not all labs look for rhinovirus
16. Division of Clinical Virology
August 2014
• First reports of serious respiratory disease in children in
Missouri (USA)
• Within one week, more reports of severe and
complicated respiratory disease in Illionois (USA)
• Sequencing by CDC
• 19/22 Missouri EV-D68
• 11/14 Illionois EV-D68
17. Division of Clinical Virology
Enterovirus D68 outbreak 2014
• Children (<16 years)
• 68% had prior history of wheezing
• Nearly all patients required intensive care treatment
• Many reports from other states and Canada
• Testing (sequencing) at CDC: only severe cases
19. Division of Clinical Virology
EV-D68 in USA 2014
• At least 1121 positives in 47 states
• 40% of screened patients positive for EV-D68
• Incidence now reduced
• 12 children died
• Mostly seen bronchiolitis
22. Division of Clinical Virology
patient Sex age date symptoms ICU/days Underlying conditon
1 F 1y/ 11m Feb 2014 Moderate bronchilitis-type
respiratory illness
no none
2 F 1y/ 7m May 2014 Severe respiratory illness,
intubaton, mechanical
ventilation
Yes/4 none
3 F 6m June 2014 Mild cold symptoms no Congenital heart disease
4 M 3y/ 9m June 2014 Severe respiratory illness,
intubation, mechanical
ventilation
Yes/8 Sickle cell anemia
5 M 65y July 2014 Moderate wheezing and
cough
no Lung transplantation
6 M 1 y July 2014 Severe respiratory illness,
intubation, mechanical
ventilation
Yes/5 none
7 F 6w July 2014 Feeding problem no Gastro-esophageal reflux
8 M 3y/ 10m July 2014 Severe respiratory illness,
intubation, mechanical
ventilation
Yes/1 Ex-premature
9 M 6m Aug 2014 Mild cold symptoms * Congenital heart disease
10 M 14y Aug 2014 Mild cold symptoms * Traumatic brain injury
11 F 1y/ 6m Aug 2014 Mild cold symptoms no epilepsy
12 M 1m Aug 2014 Severe respiratory illness,
intubation, mechanical
ventilation
Yes/1 Ex-premature
13 F 22y Aug 2014 Cough, SOB, fatigue No Heart transplantation
14 F 44y Aug 2014 Cough, SOB No COPD
15 M 1y/ 5m Sep 2014 Moderate wheezing, cough No Tracheomalacia, heart disease
16 F 63y Sep 2014 Asthma exacerbation no asthma
17 F 53y Sep 2014 Wheezing, pneumonia no Renal transplantation
* These children were admitted to ICU for other reasons
SOB=shortness of breath
23. Division of Clinical Virology
Is EV-D68 detected?
• QCMD: most laboratories do not detect or look for EV-D68
• Commercial assays:
• Fast-track diagnostics YES
• Argene YES
• GenMark NOT
• Cepheid YES, but not validated
• FilmArray YES, but rhino/entero together
• Luminex YES, but rhino/entero together
• Pathofinder MLPA YES, but rhino/entero together
• Seegene, NOT
• bioMerieux NASBA NucliSENS EasyQ Enterovirus, NOT
• Laboratory Developed Tests: not always
• Routinely, enterovirus is not always included for respiratory diagnostics
24. Division of Clinical Virology
What’s up
• Several labs have started looking for EV-D68
• Sequencing provides most info (a lot of work)
• 2 new targeted specific PCRs to detect EV-D68 available
25. Division of Clinical Virology
To take home
• In the USA in 2014: EV-D68 outbreak ongoing
• In the UMCG EV-D68 several severe infections
• Few labs have routine screening tests that detect EV-
D68
• How much EV-D68 is there really in Europe???
26. Division of Clinical Virology
How is the situation in Europe?
ECDC: I see no problem…………
29. 0
5
10
15
20
25
30
35
40
45
50
27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48
NumberofEV-D68positives
Week
NA
Clade B
Clade A
ESCV 2014, Prague
Epidemiological curve
July 1st December 1st
*17 samples are not included in this graph, due to a lack of sampling
date
30. EV-D68 / EV Genus
0 %
1-5 %
5-20 %
20-35 %
*
*
*
European detection rates per country
*
• 42 laboratories
from 18 countries
• 17,248 samples
tested
• 389 EV-D68
positives
Division of Clinical Virology
31. Norway Oslo NIPH 66 25 9
Oslo Ullevål 354 71 34
Trondheim 157 101 6 49 24,9%
Sweden Stockholm Karolinska/PHI/ 30* 30 7 7 23,3%
Finland Turku UTU 700 140 10
Helsinki HUS 109 15 4
Helsinki THL 91 29 3 17 9,2%
Scotland Glasgow 488* 488 22 22 4,5%
Ireland NVRL Dublin 1010 51 4 4 7,8%
Wales Cardiff NHS 604 62 9 9 14,5%
Netherlands Erasmus MC Rotterdam 198 46 7
Leiden UMC 780 185 3
Radboud UMC 270 6 1
Regional health service Haarlem 252 62 4
UMC Groningen 2397 531 19
RIVM Bilthoven NIH 370 130 22 56 5,8%
Denmark Statens serum institut SSI 252 50 8 8 16,0%
Germany Bonn 351 35 1
Freiburg 136* 136 6
Berlin, Robert Koch Institut *** 1658 58 15
Leipzig, Institute of Virology 364 93 9 31 9,6%
Poland Warsaw NIH 144 22 0 0
Romenia Bucharest 56 0 0 0
Austria Vienna 778 47 1 1 2,1%
Slovenia Ljubljana 702 234 48 48 20,5%
Italy Milan 176 97 4
Pavia 195* 195 9 13 4,5%
Luxembourg Luxembourg 19* 19 1 1 5,3%
France Lyon/Nat ref center EV 1589 439 39
Clermont-Ferrand/Nat ref center EV 710 191 25
Brest 199 86 9
Caen 367 175 22
Dijon 159 37 5
Paris 49 25 0
Saint-Etienne 104 36 6
Strasbourg 203 102 9
Versailles 109 34 2 117 10,4%
Spain Barcelona 529 53 5
Valencia 458 89 0
Santander 15* 15 0
Valladolid 33* 33 1 6 3,2%
Portugal Lisbon 17 0 0 0
Total number of countries** Total number of labs
17 42 17248 4273 389
EV68/EV Genus (%)Country lab/city Tested EV Genus (= EV and/or HRV) EV-D68 Total/Country
Division of Clinical Virology
32. Underlying disease presented in the different age groups
Statistic note:
55% (n=17) of the 31 EV68 positive patients older than 17 year were immunocompromised.
Only 8% (n=8) of the 100 EV68 positive patients younger than 17 were immunocompromised.
This difference is very significant: odds ratio 13,9 (95% CI 4,6 – 44,0), p < 0,001 (Chi-Square Test)
0-1 120 20(16,7%) 3(2,5%) 10(8,3%) 58(48,3%) 29(24,2%)
2-5 135 27(20,0%) 5(3,7%) 12(8,9%) 28(20,7%) 63(46,7%)
6-16 56 16(28,6%) 1(1,8%) 6(10,7%) 11(19,6%) 22(39,3%)
≥17 78 9(11,5%) 17(21,8%) 5(6,4%) 14(17,9%) 33(42,3%)
Total 389 72(18,5%) 26(6,7%) 33(8,5%) 111(28,5%) 147(37,8%)
age EV68positive
Underlying disease
Not assignedNoneNon respiratory illnessImmunocompromisedChronicrespiratory illness
33. Division of Clinical Virology
AFP case France
• Boy age 4
• 20 September meningitis syndrome
• 190 leukocytes in CSF, 92% lymphocytes
• 27 September paralysis en dysphagia
• EV-D68 in faeces and nasopharynx
34. Division of Clinical Virology
Clinical picture reported from these countries
• Respiratory complaints
• 3 Acute Flacid Paralysis (France and Norway)
• 1 death
• A lot of children with underlying disease
• Also adults
• Some real outbreaks: Wales and Slovenia
• Different approach of diagnostics for viral infections
gives a different picture in different countries
37. Nr of Samples
25
10
5
1
Yamagata ’10
Clade C
Fermon
A2
B
A1
Colors represents the country of origin.
LEGEND
NOR GER
FIN SVN
IRE ITA
WAL FRA
NLD SPA
DNK USA
38. Division of Clinical Virology
• In USA 2014: EV-D68 outbreak
• In Europa circulation of same EV-D68 genotypes
• Different approach of diagnostics for viral infections
gives a different picture in different countries
How do we take care that “emerging viruses” do
become detected?
39. Division of Clinical Virology
Conclusion
• Highlight the need for incorporating molecular
diagnostics into routine testing
detection and identification of these viruses could
help in explaining serious illness, giving guidance to
medical care and preventing unnecessary treatment
with antibiotics
40. Division of Clinical Virology
TYPENED and REGIOtype
• Sequencing of enterovirus,
parechovirus, rhinovirus and
norovirus in the region and in
real time
42. The AID-Stewardship Portfolio
• The Antibiotic/Antimicrobial Stewardship
• The Infection Control Stewardship
• The Diagnostic Stewardship
Determine and communicate the value of molecular
diagnostics!
– Take the lead (use of POC/POI; E-health)
– Cost effectiveness
– Awareness (communicate)
Division of Clinical Virology
43. Austria:
-(Department of Virology, Medical University of Vienna) Theresia Popow-Kraupp, Stephan W. Aberle.
Denmark:
-(Virus Surveillance and Research Unit, Department of Microbiological Diagnostics and Virology, Statens Serum Institut and Clinical Institute, University of Southern Denmark) Thea Kølsen Fischer;
-(National WHO Polio Reference Laboratory at Statens Serum Institut) Sofie Midgley;
-(Virology Unit, Department of Clinical Microbiology at Rigshospitalet) Claus Bohn Christiansen.
Finland:
-(Department of Virology, University of Turku) Matti Waris, Riikka Österback, Tytti Vuorinen;
-(National Institute for Health and Welfare, Virology unit, Helsinki) Carita Savolainen-Kopra, Francesca Latronico#, Soile Blomqvist, Niina Ikonen; (#*European Public Health Microbiologytraining programme (EUPHEM), European Centre for Disease Prevention and Control, Stockholm, Sweden)
-(Department of Virology and Immunology, University of Helsinki and Helsinki University Hospital)
Maija Lappalainen, Anne Jääskeläinen, Teemu Smura.
France:
-(Microbiology laboratory, University hospital of Brest) Léa Pilorge, Marie-Christine Legrand-Quillien, Christopher Payan;
-(Virology laboratory, University hospital of Caen) Joëlle Petitjean, Astrid Vabret, Mélanie Ribault;
-(National Reference Center for Enteroviruses and Parechoviruses, University Hospital of Clermont-Ferrand) Audrey Mirand, Hélène Peigue-Lafeuille, Cécile Henquell;
-(Virology laboratory, University hospital of Dijon) Catherine Manoha, Jean-Baptiste Bour, Magali Darniot;
-(Virology laboratory, National Reference Center for Enteroviruses and Parechoviruses, Hospices Civils de Lyon) Isabelle Schuffenecker, Laurence Josset, Bruno Lina;
-(Université Paris Diderot, Sorbonne Paris Cité, Microbiology laboratory, Hôpital Saint-Louis, APHP, Paris) Jérôme Le Goff, Séverine Mercier-Delarue, Catherine Scieux;
-(Laboratory of infectious agents and hygiene, University Hospital of Saint-Etienne, Saint-Etienne) Sylvie Pillet, Bruno Pozzetto;
-(Virology institute, University hospital of Strasbourg) Quentin Lepiller, Samira Fafi-Kremer, Françoise Stoll-Keller;
-(Microbiology laboratory, Hospital of Versailles) Stéphanie Marque-Juillet; Aymeric Coutard, Marlène Amara.
Germany:
-(Berlin, Robert Koch Institute, National Reference Centre for Poliomyelitis and Enteroviruses) Sindy Böttcher, Sabine Diedrich; The Robert Koch Institute collateddata from the followingDepartments and Institutes: Institute of Virology and Immunobiology,University Hospitalof Würzburg, Christiane Prifert, Benedikt Weißbrich; Institute of Virology,University Hospital of Düsseldorf, Ortwin Adams;
Department of Virology,Labor Berlin - Charite VivantesGmbH), Angela Stein, Jörg Hofmann; Department of Infectious Diseases,Virology,University HospitalHeidelberg,Paus Schnitzler;
-(Institute of Virology, University of Bonn Medical Centre) Anna Maria Eis-Hübinger, Souhaib Aldabbagh, Ulrike Reber;
-(Institute of Virology, Albert-Ludwigs University Freiburg) Marcus Panning, Daniela Huzly, Sibylle Bierbaum;
-(Institute of Virology, University of Leipzig) Uwe G. Liebert, Melanie Maier.
Ireland:
-(National Virus Reference Laboratory, University College Dublin) Michael J. Carr, Gráinne Tuite, Jorge Abboud Guerra ,Joanne O’Gorman, CillianDe Gascun
Italy:
-(University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia) Fausto Baldanti; (Fondazione IRCCS Policlinico San Matteo, Pavia), Antonio Piralla
-(Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Pediatric Highly Intensive Care Unit), Susanna Esposito, Nicola Principi, Luca Ruggiero
Luxembourg:
-(Dudelange, Laboratoire National de Santé) Matthias Opp
Netherlands:
-(Bilthoven, Centre for Infectious Disease Research, Diagnostics and Screening, National Institute of Public Health and the Environment) Adam Meijer, Harrievan der Avoort, Kimberley Benschop; (Bilthoven, Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute of Public Health) Marit de Lange; (Utrecht, Netherlands institute for health services research) Gé Donker;
-(University Medical Center Groningen) Hubert Niesters, Randy Poelman, Coretta van Leer-Buter, Renze Borger, Liesbeth Scholvinck;
-(Haarlem, Regional Laboratory for Public Health Kennemerland) Wil van der Reijden, Dick Veenendaal;
-(Department of Medical Microbiology, Leiden University Medical Center Leiden) Eric C.J. Claas, Ann C.T.M. Vossen ;
-(Nijmegen, Department of Medical Microbiology, Radboud University Medical Center) Janette Rahamat-Langendoen, Willem J.G. Melchers ;
-(Rotterdam, ErasmusMC, Department of Viroscience) Marion P.G. Koopmans, Annemiek A. van der Eijk, Suzan D. Pas
Norway:
-(Department of Medical Microbiology, Oslo University Hospital) Anne-Marte Bakken Kran;
-(Oslo, Norwegian Institute of Public Health) Karoline Bragstad, Susanne Gjeruldsen Dudman;
-(Trondheim, Department of Medical Microbiology, St.Olavs University Hospital) Andreas Christensen, Sidsel Krokstad
Poland:
-(National Institute of Public Health-NIH Warsaw) Katarzyna Pancer, Edyta Abramczuk.
Portugal:
-(Lisbon, National Influenza Reference Laboratory) Raquel Guiomar, Pedro Pechirra, Paula Cristovão, Ines Costa.
Romania:
-(Bucharest, Cantacuzino National Research and Development Institute for Microbiology and Immunology) Cristina Tecu, Emilia Lupulescu, Carmen Cherciu.
Scotland:
-(West of Scotland Specialist Virology Centre Glasgow) Emily Goldstein, Susan Bennett, Amanda Bradley-Stewart, Rory Gunson.
Slovenia:
-(Ljubljana, Laboratory for Public Health Virology. National Laboratory of Health, Environment and Food) Natasa Berginc, Katarina Prosenc.
Spain:
-(Respiratory Virus Unit/Virology Section, University Hospital Vall d’Hebron, Barcelona) Magda Campins, Laura Gimferrer, Andres Anton;
-(Virology Laboratory, Genomics and Health Area, FISABIO-Public Health, Generalitat Valenciana, Valencia / CIBERESP, Instituto de Salud Carlos III) F. Xavier López-Labrador; Laura Cano Pérez; (Vaccines Research Area, FISABIO-Public Health, Generalitat Valenciana, Valencia) Joan Puig-Barberá;
-(Microbiology Service, General Hospital of Valencia) Concepción Gimeno Cardona, M Dolores Ocete Mochón;
-(Microbiology Service, Hospital Clinico of Valencia) Javier Buesa, David Navarro;
-(University Hospital of Valladolid) R. Ortiz de Lejarazu Leonardo, Iván Sanz Muñoz, Silvia Rojo;
-(Service of Microbiology, University Hospital Marqués de Valdecilla-IDIVAL, Santander) Mónica Gozalo-Margüello, Jesús Agüero Balbín.
Sweden:
-(Stockholm, Department of Clinical Microbiology, Karolinska University Hospital) Jan Albert, Agneta Samuelson, Maria Rotzén Östlund, Robert Dyrdak
-(Stockholm, Public Health Agency of Sweden) Mia Brytting, Elenor Hauzenberger, Katherina Zakikhany
-(Stockholm, Astrid Lindgren Children's Hospital) Margareta Eriksson
Wales:
-(Public Health Wales Microbiology Cardiff, University Hospital of Wales) Catherine Moore.
European Centre for Disease Prevention and Control (Stockholm Sweden)
-Eeva Broberg, Pasi Penttinen.
Quality Control for Molecular Diagnostics (Scotland/United Kingdom)
-Elaine McCulloch, Caterina Di Lorenzo, Paul Wallace, Anton Van Loon
List of participants ESCV-ECDC
Enterovirus D68 ad-hoc study group